MyD88 : a key regulator of chemoresistance, differentiation and hypoxia resistance in cancer stem cells?
Citation:Aoife Cooke, 'MyD88 : a key regulator of chemoresistance, differentiation and hypoxia resistance in cancer stem cells?', [thesis], Trinity College (Dublin, Ireland). School of Medicine. Discipline of Histopathology & Morbid Anatomy, 2013, pp 273
Cooke TCD THESIS 10248 MyD88 a key.pdf (PDF) 124.9Mb
Ovarian cancer, the leading cause of gynaecologic cancer deaths in the western world is characterised by high rates of chemoresistant recurrence. While in primary cases, differentiation status of the tumour is considered a primary prognostic indicator, in recurrent disease this is no longer the case. Recurrent disease could be explained by the cancer stem cell theory. Cancer stem cells (CSCs) are a minority population of cancer cells with stem like properties including enhanced proliferation. CSCs are considered a potential source of recurrent disease.
Author: Cooke, Aoife
Publisher:Trinity College (Dublin, Ireland). School of Medicine. Discipline of Histopathology & Morbid Anatomy
Note:TARA (Trinity’s Access to Research Archive) has a robust takedown policy. Please contact us if you have any concerns: email@example.com
Type of material:thesis
Availability:Full text available